Multiple Sclerosis

Latest News

Vidofludimus Calcium to Receive U.S. Patent for Treatment of Relapsing MS
Vidofludimus Calcium to Receive U.S. Patent for Treatment of Relapsing MS

November 16th 2023

Vidofludimus calcium is a potential first-in-class nuclear receptor related 1 (Nurr1) activator and a selective dihydroorotate dehydrogenase (DHODH) inhibitor.

Study Finds Higher B-Cell Levels in African American Patients with Multiple Sclerosis
Study Finds Higher B-Cell Levels in African American Patients with Multiple Sclerosis

November 8th 2023

Intranasal Foralumab for Multiple Sclerosis Now Approved by FDA for At-Home Dosing
Intranasal Foralumab for Multiple Sclerosis Now Approved by FDA for At-Home Dosing

October 20th 2023

PML, a Rare Side Effect of Tysabri, Found to Worsen Long-Term Disability in Patients with MS
PML, a Rare Side Effect of Tysabri, Found to Worsen Long-Term Disability in Patients with MS

October 11th 2023

Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.